Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Singh

Showing results (271-280 of 505) with videos related to

Pageof 51
Sort By:
ERJ Open Research|May 28, 2026
A randomised controlled trial of EP395, a novel anti-inflammatory macrolide, in stable COPD patientsHenrik Watz, Stephanie Korn, Oliver Kornmann, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 13, 2019
An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPDDave Singh, Anthony D D'Urzo, James F Donohue, et al.
BMJ Open|January 8, 2016
Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthmaNestor A Molfino, Piotr Kuna, Jonathan A Leff, et al.
Respiratory Research|May 18, 2016
Electronic cigarette exposure triggers neutrophil inflammatory responsesAndrew Higham, Nicholas J W Rattray, Jennifer A Dewhurst, et al.
Thorax|March 29, 2011
Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokersDave Singh, Steven M Fox, Ruth Tal-Singer, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 1, 2017
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysisGustavo J Rodrigo, David Price, Antonio Anzueto, et al.
The European Respiratory Journal|April 13, 2012
Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459Dave Singh, Paul Cadden, Michael Hunter, et al.
Respiratory Medicine|September 1, 2015
Tiotropium + olodaterol shows clinically meaningful improvements in quality of lifeDave Singh, Gary T Ferguson, Josef Bolitschek, et al.
Advances in Therapy|June 25, 2024
A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate-Severe AsthmaGabriel Garcia, Sven C van Dijkman, Ian Pavord, et al.
Pulmonary Pharmacology & Therapeutics|January 15, 2018
Realising the potential of various inhaled airway challenge agents through improved delivery to the lungsAnne J Lexmond, Dave Singh, Henderik W Frijlink, et al.
Pageof 51

Showing results (271-280 of 505) with videos related to

Sort By:
Pageof 51
ERJ Open Research|May 28, 2026
A randomised controlled trial of EP395, a novel anti-inflammatory macrolide, in stable COPD patientsHenrik Watz, Stephanie Korn, Oliver Kornmann, et al.
International Journal of Chronic Obstructive Pulmonary Disease|December 13, 2019
An Evaluation Of Single And Dual Long-Acting Bronchodilator Therapy As Effective Interventions In Maintenance Therapy-Naïve Patients With COPDDave Singh, Anthony D D'Urzo, James F Donohue, et al.
BMJ Open|January 8, 2016
Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthmaNestor A Molfino, Piotr Kuna, Jonathan A Leff, et al.
Respiratory Research|May 18, 2016
Electronic cigarette exposure triggers neutrophil inflammatory responsesAndrew Higham, Nicholas J W Rattray, Jennifer A Dewhurst, et al.
Thorax|March 29, 2011
Induced sputum genes associated with spirometric and radiological disease severity in COPD ex-smokersDave Singh, Steven M Fox, Ruth Tal-Singer, et al.
International Journal of Chronic Obstructive Pulmonary Disease|April 1, 2017
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysisGustavo J Rodrigo, David Price, Antonio Anzueto, et al.
The European Respiratory Journal|April 13, 2012
Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459Dave Singh, Paul Cadden, Michael Hunter, et al.
Respiratory Medicine|September 1, 2015
Tiotropium + olodaterol shows clinically meaningful improvements in quality of lifeDave Singh, Gary T Ferguson, Josef Bolitschek, et al.
Advances in Therapy|June 25, 2024
A Simulation Study of the Effect of Clinical Characteristics and Treatment Choice on Reliever Medication Use, Symptom Control and Exacerbation Risk in Moderate-Severe AsthmaGabriel Garcia, Sven C van Dijkman, Ian Pavord, et al.
Pulmonary Pharmacology & Therapeutics|January 15, 2018
Realising the potential of various inhaled airway challenge agents through improved delivery to the lungsAnne J Lexmond, Dave Singh, Henderik W Frijlink, et al.
Pageof 51